文献速递泌尿生殖腹部MR

VI-RADS评估膀胱癌肌层浸润的多中心前瞻性验证研究

The validity, reliability, and reviewer acceptance of VI-RADS in assessing muscle invasion by bladder cancer: a multicenter prospective study.
PubMed 文献 · Eur Radiol · 2021-02-19

该多中心前瞻性研究纳入331例疑似或未治疗膀胱癌患者,术前行膀胱多参数MRI,4名放射科医师独立应用VI-RADS评分,以首次和二次经尿道膀胱肿瘤电切术病理为参考标准。结果显示VI-RADS预测肌层浸润诊断效度高,观察者间一致性很好(κ=0.93),但VI-RADS 2和3评分仍需进一步修改以提高诊断效度。

要点

  • VI-RADS 4和5预测肌层浸润风险高,首次TURBT后分别为69.6%和96.4%。
  • 首次TURBT后预测肌层浸润最佳截断值为>VI-RADS 3,敏感度84.1%、特异度92.3%。
  • VI-RADS 2和3中肌层浸润比例不可忽视,首次TURBT后分别为21.8%和45.8%。
英文原文(摘要)· 点击展开

OBJECTIVE: To assess diagnostic validity and reliability of VI-RADS in predicting muscle invasion by bladder cancer (BCa) and evaluate reviewer acceptance of VI-RADS for clinical routine.

METHODS: A prospective multicenter study enrolled 331 patients with suspected/untreated BCa who underwent preoperative multiparametric MRI examination (mp-MRI) of the urinary bladder. Four experienced radiologists independently evaluated all mp-MRI using VI-RADS. The diagnostic validity of VI-RADS for predicting muscle invasion by BCa was calculated using histopathology of the first transurethral resection bladder tumor (TURBT) and second TURBT as the reference standards. The kappa statistics (κ) were applied to assess the interreader agreement (IRA). Reviewer acceptance was evaluated with questionnaires.

RESULTS: The risk of muscle invasion in VI-RADS 2, 3, 4, and 5 after the first and second TURBT was 21.8%, 45.8%, 69.6%, and 96.4% and 24.4%, 58.3%, 87%, and 99.2%, respectively. The overall diagnostic validity of VI-RADS was high. The optimal cut-off value for predicting muscle invasion after first TURBT was > VI-RADS 3 (sensitivity = 84.1% and specificity = 92.3%), and after second TURBT was > VI-RADS 2 (sensitivity = 89.9% and specificity = 90.1%). VI-RADS categorization showed a very good IRA (κ = 0.93). Reviewers fully agreed with the statement, "The application of structured reporting of bladder tumor should be encouraged" (score = 20).

CONCLUSIONS: VI-RADS showed high diagnostic validity and reliability for predicting muscle invasion by BCa, especially VI-RADS 4 and 5. However, VI-RADS 2 and 3 require further modifications to enhance their diagnostic validity. VI-RADS is highly encouraged to be used in daily practice.

KEY POINTS: • VI-RADS showed high diagnostic validity and reliability in predicting BCa muscle invasion, especially VI-RADS 4 and 5. • In VI-RADS 2 and 3, we observed a notable percentage of BCa with muscle invasion and this would require further modifications to enhance the diagnostic validity for these scores. • Overall VI-RADS is well-accepted by radiologists who recommend it for daily practice.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Metwally MI, Zeed NA, Hamed EM, et al. The validity, reliability, and reviewer acceptance of VI-RADS in assessing muscle invasion by bladder cancer: a multicenter prospective study. Eur Radiol. 2021. PMID: 33606105. doi:10.1007/s00330-021-07765-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。